Thymine

Thymine

SCHEMBL5176783

Br.Cc1c[nH]c(=O)[nH]c1=O

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Thymine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ATAD2 Q6PL18 1/20 0.95
▸ DPYD Q12882 5/20 0.50
▸ MAPT P10636 3/20 0.50
▸ GAA P10253 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ CYP19A1 P11511 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ THPO P40225 1/20 0.50
▸ MTOR P42345 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ HBB P68871 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ KDM4C Q9H3R0 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thymine SCHEMBL17201833 0.97 ATAD2 (1.00) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL750450 0.97 ATAD2 (1.00) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL29669526 0.97 — —
Thymine SCHEMBL15323914 0.97 ATAD2 (1.00) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL5235 0.97 — —
Thymine SCHEMBL935833 0.95 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL2724033 0.95 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL8649294 0.95 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL3500839 0.95 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL4811815 0.95 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814867-A2 ARYL PYRIMIDYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, THEIR USE AS ANTIMICROBIAL AGENTS INSTITUT PASTEUR (FR) 2007-08-08 — — EP disclosed
WO-2006048336-A2 ARYL PYRIMIDYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, THEIR USE AS ANTIMICROBIAL AGENTS INSTITUT PASTEUR (FR) 2006-05-11 — — WO disclosed
EP-0584185-A1 TREATMENT OF FATIGUE SYNDROME WITH CHOLINESTERASE INHIBITORS Snorrason, Ernir (IS) 1994-03-02 — — EP disclosed
WO-1992020327-A1 TREATMENT OF FATIGUE SYNDROME WITH CHOLINESTERASE INHIBITORS SNORRASON ERNIR (IS) 1992-11-26 — — WO disclosed
Send feedback